Literature DB >> 12399111

Improved neurotensin-vector-mediated gene transfer by the coupling of hemagglutinin HA2 fusogenic peptide and Vp1 SV40 nuclear localization signal.

Iván Navarro-Quiroga1, Juan Antonio González-Barrios, Fernando Barron-Moreno, Víctor González-Bernal, Daniel B Martinez-Arguelles, Daniel Martinez-Fong.   

Abstract

Recently we reported that neurotensin-SPDP-poly-L-lysine (NT-vector) is able to bind plasmid DNA (NT-polyplex) and polyfect cells expressing the high-affinity neurotensin receptor (NTRH) although with low transfecting efficiency: in vitro, 6.5+/-1.5%, and in vivo, 5+/-4%. In this work, we attempted to increase the transfecting efficiency by integrating the hemagglutinin HA2 fusogenic peptide and the Vp1 nuclear localization signal of SV40 to the NT-polyplex (fusogenic-karyophilic-NT-polyplex). Confocal microscopy and flow cytometry analysis showed that the fusogenic-karyophilic-NT-polyplex produced mostly nuclear localization of the plasmid DNA in NTRH-bearing N1E-115 cells. About 50% of N1E-115 cells internalized and expressed the reporter gene when the plasmid DNA was transferred by the fusogenic-karyophilic-NT-polyplex. Although to a less extent, the addition of each viral peptide separately to NT-polyplex (fusogenic-NT-polyplex or karyophilic-NT-polyplex) improved polyfection. Fusogenic-NT-polyplex produced 22.41+/-5.96% of internalization and 20.35+/-0.82% of expression in N1E-115 cells, whereas karyophilic-NT-polyplex yielded 13.75+/-3.88% and 10.94+/-2.04%, respectively. Basal internalization and expression were detected in N1E-115 cells in the presence of 100 nM SR-48692 and in NTRH-lacking cells. The fusogenic-karyophilic-NT-polyplex was microinjected into the substantia nigra to test its ability for gene transfer in vivo. Fusogenic-karyophilic-NT-polyplex internalization was observed within dopamine neurons only. Reporter gene expression was observed in a high proportion of dopamine neurons up to 60 days after NT-polyfection. Both internalization and expression were prevented by SR-48692. Our results show that the fusogenic-karyophilic-NT-polyplex is a highly efficient and specific gene vector and encourage its use to transfer gene of physiological interest to NTRH-bearing neurons. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399111     DOI: 10.1016/s0169-328x(02)00396-0

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  17 in total

1.  Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine).

Authors:  In-Kyu Park; Jurate Lasiene; Shinn-Huey Chou; Philip J Horner; Suzie H Pun
Journal:  J Gene Med       Date:  2007-08       Impact factor: 4.565

2.  Vitamin B12-impaired metabolism produces apoptosis and Parkinson phenotype in rats expressing the transcobalamin-oleosin chimera in substantia nigra.

Authors:  Carlos Enrique Orozco-Barrios; Shyue-Fang Battaglia-Hsu; Martha Ligia Arango-Rodriguez; Jose Ayala-Davila; Celine Chery; Jean-Marc Alberto; Henry Schroeder; Jean-Luc Daval; Daniel Martinez-Fong; Jean-Louis Gueant
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

3.  The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1.

Authors:  Alberto E Ayala-Sarmiento; Daniel Martinez-Fong; José Segovia
Journal:  Cell Mol Neurobiol       Date:  2015-03-14       Impact factor: 5.046

Review 4.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

Review 5.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

6.  The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease.

Authors:  Luis F Razgado-Hernandez; Armando J Espadas-Alvarez; Patricia Reyna-Velazquez; Arturo Sierra-Sanchez; Veronica Anaya-Martinez; Ismael Jimenez-Estrada; Michael J Bannon; Daniel Martinez-Fong; Jorge Aceves-Ruiz
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

7.  Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.

Authors:  Nancy G Hernandez-Chan; Michael J Bannon; Carlos E Orozco-Barrios; Lourdes Escobedo; Sergio Zamudio; Fidel De la Cruz; Jose L Gongora-Alfaro; Juan Armendáriz-Borunda; David Reyes-Corona; Armando J Espadas-Alvarez; Yazmin M Flores-Martínez; Jose Ayala-Davila; Maria E Hernandez-Gutierrez; Lenin Pavón; Refugio García-Villegas; Rasajna Nadella; Daniel Martinez-Fong
Journal:  J Biomed Sci       Date:  2015-07-22       Impact factor: 8.410

8.  Fusion of a Short HA2-Derived Peptide Sequence to Cell-Penetrating Peptides Improves Cytosolic Uptake, but Enhances Cytotoxic Activity.

Authors:  Ines Neundorf; Robert Rennert; Jan Hoyer; Franziska Schramm; Kristin Löbner; Igor Kitanovic; Stefan Wölfl
Journal:  Pharmaceuticals (Basel)       Date:  2009-09-25

9.  Optimizing NTS-polyplex as a tool for gene transfer to cultured dopamine neurons.

Authors:  Daniel Hernandez-Baltazar; Daniel Martinez-Fong; Louis-Eric Trudeau
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 10.  Nonviral approaches for neuronal delivery of nucleic acids.

Authors:  Jamie M Bergen; In-Kyu Park; Philip J Horner; Suzie H Pun
Journal:  Pharm Res       Date:  2007-10-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.